SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-10-091949
Filing Date
2010-04-23
Accepted
2010-04-23 17:23:20
Documents
4
Period of Report
2010-05-25
Effectiveness Date
2010-04-23

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT ddef14a.htm DEF 14A 461843
2 GRAPHIC g75030g03n83.jpg GRAPHIC 105254
3 GRAPHIC g75030g37n39.jpg GRAPHIC 17244
4 GRAPHIC g75030g51a90.jpg GRAPHIC 128428
  Complete submission text file 0001193125-10-091949.txt   809453
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 10768145
SIC: 2834 Pharmaceutical Preparations